EFTR — Effector Therapeutics Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright
Brief: eFFECTOR Therapeutics Q1 Net Income USD -8.834 Million
eFFECTOR Therapeutics Inc expected to post a loss of $2.16 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-US banks, Hertz, Spirit,
U.S. STOCKS ON THE MOVE-Delta Air Lines, Alternus Clean Energy, US banks
eFFECTOR Therapeutics slumps on plans to stop development of lung cancer therapy
eFFECTOR Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Effector Therapeutics Received A Letter From Nasdaq Stating That Co Has Regained Compliance With Minimum Bid Price Requirement
Brief: Effector Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Effector Therapeutics Announces Reverse Stock Split
Brief: eFFECTOR Therapeutics Says Zotatifin Generally Well Tolerated As Dose Escalation Continues
Brief: eFFECTOR Receives U.S. FDA Fast Track Designation For Zotatifin In Combination With Fulvestrant And Abemaciclib For Treatment Of Er+/Her2- Advanced Metastatic Breast Cancer
Brief: eFFECTOR Therapeutics Q3 Net Income USD -8.303 Million
eFFECTOR Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Effector Therapeutics Appoints Caroline Loewy To Board Of Directors
eFFECTOR Therapeutics Inc reports results for the quarter ended in June - Earnings Summary